<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Johnson &amp; Johnson - Google Finance</title>
<description>News for Johnson &amp; Johnson - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:JNJ&amp;amp;client=news-rss&amp;amp;ei=Ov6gUbC9EMTs0gHHWQ</link>
<image>
<title>News for Johnson &amp; Johnson - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:JNJ&amp;amp;client=news-rss&amp;amp;ei=Ov6gUbC9EMTs0gHHWQ</link>
</image>
<item>
<title>Johnson &amp;amp; Johnson Is Reinventing The Party Drug Ketamine To Treat Depression</title>
<link>http://www.forbes.com/sites/matthewherper/2013/05/23/johnson-johnson-is-reinventing-the-party-drug-ketamine-to-treat-depression/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982071194907</guid>
<pubDate>Thu, 23 May 2013 17:34:01 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.forbes.com/sites/matthewherper/2013/05/23/johnson-johnson-is-reinventing-the-party-drug-ketamine-to-treat-depression/&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson Is Reinventing The Party Drug Ketamine To Treat Depression&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Forbes&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Until joining the company a few years ago, J&amp;amp;J neuroscience R&amp;amp;D head Husseini Manji led the mood and anxiety disorders program at the National Institutes of Health.&lt;/div&gt;
&lt;a href=&quot;http://www.tgdaily.com/hardware-brief/71868-ketamine-may-cure-depression&quot;&gt;Ketamine may cure depression&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;TG Daily&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson says it will submit 10 new medicines for approval by 2017</title>
<link>http://www.nj.com/business/index.ssf/2013/05/johnson_johnson_says_it_will_s.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982070551030</guid>
<pubDate>Thu, 23 May 2013 17:37:20 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nj.com/business/index.ssf/2013/05/johnson_johnson_says_it_will_s.html&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson says it will submit 10 new medicines for approval by 2017&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;The Star-Ledger - NJ.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Johnson &amp;amp; Johnson, the world&amp;#39;s biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017.&lt;/div&gt;
&lt;a href=&quot;http://www.10news.com/lifestyle/health/johnson-johnson-forecasts-10-new-drug-applications-by-201705232013&quot;&gt;Johnson &amp;amp; Johnson forecasts 10 new drug applications by 2017&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;10News&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.foxbusiness.com/news/2013/05/23/johnson-johnson-to-submit-10-new-product-filings-by-2017/&quot;&gt;Johnson &amp;amp; Johnson to Submit 10 New Product Filings by 2017&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Fox Business&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson to Discontinue Metal-on-Metal Hip Implants</title>
<link>http://www.drugwatch.com/2013/05/24/johnson-and-johnson-discontinues-all-metal-hips/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982071662720</guid>
<pubDate>Fri, 24 May 2013 17:11:15 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.drugwatch.com/2013/05/24/johnson-and-johnson-discontinues-all-metal-hips/&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson to Discontinue Metal-on-Metal Hip Implants&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;DrugWatch.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;In response to a staggering decline in sales and a recent U.S. Food and Drug Administration (FDA) proposal to tighten regulations on all-metal hip implants, Johnson &amp;amp; Johnson has opted to halt the sale of its metal-on-metal products. DePuy Orthopaedics ...&lt;/div&gt;
&lt;a href=&quot;http://charlottesville.legalexaminer.com/defective-and-dangerous-products/johnson-johnson-depuy-stopping-production-of-allmetal-hip-replacement-products.aspx?googleid=308712&quot;&gt;Johnson &amp;amp; Johnson (DePuy) Stopping Production of All-Metal Hip Replacement ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Legal Examiner&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.sfgate.com/business/prweb/article/DePuy-ASR-Hip-Lawsuit-News-Bernstein-Liebhard-4547524.php&quot;&gt;DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;San Francisco Chronicle (press release)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>New Stock Coverage: Can Johnson &amp;amp; Johnson Be Market&amp;#39;s Band-Aid?</title>
<link>http://www.minyanville.com/trading-and-investing/stocks/articles/New-Stock-Coverage253A-Can-Johnson-2526/5/23/2013/id/49980</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982071061195</guid>
<pubDate>Thu, 23 May 2013 13:30:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.minyanville.com/trading-and-investing/stocks/articles/New-Stock-Coverage253A-Can-Johnson-2526/5/23/2013/id/49980&quot; style=&quot;font-size:1.2em&quot;&gt;New Stock Coverage: Can Johnson &amp;amp; Johnson Be Market&amp;#39;s Band-Aid?&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Minyanville.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(The follicularly-challenged central banker must truly be tearing his hair out right about now, for Rogaine maker Johnson &amp;amp; Johnson (JNJ) has just been assigned a “Sell” rating.) Thus in the space of one spacy session, investors learned the age-old ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson Stock Checkup for May</title>
<link>http://www.fool.com/investing/general/2013/05/20/johnson-johnson-stock-checkup-for-may.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982067463375</guid>
<pubDate>Mon, 20 May 2013 22:34:23 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.com/investing/general/2013/05/20/johnson-johnson-stock-checkup-for-may.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson Stock Checkup for May&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 20, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;We have checkups for our bodies, our teeth, and even our cars. Why not do the same for our stocks? With that in mind, here is an inaugural monthly checkup for Johnson &amp;amp; Johnson (NYSE: JNJ ) stock. Let&amp;#39;s look at three key areas to find out J&amp;amp;J&amp;#39;s stock ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson, IVCI, AVI-SPL Address Cloud Managed Services for June ...</title>
<link>http://www.sfgate.com/business/prweb/article/Johnson-Johnson-IVCI-AVI-SPL-Address-Cloud-4541205.php</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982070349886</guid>
<pubDate>Thu, 23 May 2013 14:11:08 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sfgate.com/business/prweb/article/Johnson-Johnson-IVCI-AVI-SPL-Address-Cloud-4541205.php&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson, IVCI, AVI-SPL Address Cloud Managed Services for June ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;San Francisco Chronicle (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;The panelists will include: Steve Bleiberg, Johnson &amp;amp; Johnson Technology manager in IT shared Services, Chris Bottger, IVCi Senior Vice President-Collaboration Services and Tim Reik, AVI-SPL Senior Vice President of Services Operations.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>How Dividends Change the Game for Johnson &amp;amp; Johnson Stock</title>
<link>http://www.fool.com/investing/general/2013/05/20/how-dividends-change-the-game-for-johnson-johnson.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.fool.com/investing/general/2013/05/20/how-dividends-change-the-game-for-johnson-johnson.aspx</guid>
<pubDate>Mon, 20 May 2013 18:03:21 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.com/investing/general/2013/05/20/how-dividends-change-the-game-for-johnson-johnson.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;How Dividends Change the Game for Johnson &amp;amp; Johnson Stock&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 20, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Today, we&amp;#39;ll dive deeper into health care and consumer products giant Johnson &amp;amp; Johnson (NYSE: JNJ ) . Owning Johnson &amp;amp; Johnson stock as a dividend play makes all kinds of sense, because the company scores better than the Dow Jones Industrial ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson Pharmaceuticals Segment Poised to Continue Driving ...</title>
<link>http://www.marketwatch.com/story/johnson-johnson-pharmaceuticals-segment-poised-to-continue-driving-growth-with-more-than-10-potential-new-product-filings-by-2017-2013-05-23</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.marketwatch.com/story/johnson-johnson-pharmaceuticals-segment-poised-to-continue-driving-growth-with-more-than-10-potential-new-product-filings-by-2017-2013-05-23</guid>
<pubDate>Thu, 23 May 2013 11:31:05 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.marketwatch.com/story/johnson-johnson-pharmaceuticals-segment-poised-to-continue-driving-growth-with-more-than-10-potential-new-product-filings-by-2017-2013-05-23&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson Pharmaceuticals Segment Poised to Continue Driving ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MarketWatch (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;NEW BRUNSWICK, N.J., May 23, 2013 /PRNewswire via COMTEX/ -- At a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson &amp;amp; Johnson (Janssen) announced they anticipate submitting more than 10 ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson Unveils New Corporate Branding Campaign</title>
<link>http://www.forbes.com/sites/jenniferrooney/2013/04/25/johnson-johnson-unveils-new-corporate-branding-campaign/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778132283344</guid>
<pubDate>Thu, 25 Apr 2013 21:37:44 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.forbes.com/sites/jenniferrooney/2013/04/25/johnson-johnson-unveils-new-corporate-branding-campaign/&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson Unveils New Corporate Branding Campaign&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Forbes&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;So ends the new TV spot from TBWA LA for Johnson &amp;amp; Johnson, advertising not the company&amp;#39;s baby shampoo or Band-Aids, per se, but the company itself.&lt;/div&gt;
&lt;a href=&quot;http://economictimes.indiatimes.com/news/international-business/johnson-johnson-to-introducing-corporate-branding-campaign-to-burnish-image/articleshow/19733716.cms&quot;&gt;Johnson &amp;amp; Johnson to introducing corporate branding campaign to burnish image&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Economic Times&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.marketingweek.co.uk/news/jj-launches-first-corporate-brand-campaign/4006500.article&quot;&gt;J&amp;amp;J launches first corporate brand campaign&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Marketing Week&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Shareholders blast Johnson &amp;amp; Johnson management</title>
<link>http://www.cbsnews.com/8301-34227_162-57581473/shareholders-blast-johnson-johnson-management/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778132194476</guid>
<pubDate>Thu, 25 Apr 2013 20:26:40 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.cbsnews.com/8301-34227_162-57581473/shareholders-blast-johnson-johnson-management/&quot; style=&quot;font-size:1.2em&quot;&gt;Shareholders blast Johnson &amp;amp; Johnson management&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;CBS News&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;NEW YORK Several Johnson &amp;amp; Johnson (JNJ) shareholders took the health care giant to task during its annual meeting, citing repeated product recalls, ethical lapses and excessive executive pay.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
